Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Okada

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Brain Research|February 8, 2021
Alkaline brain pH shift in rodent lithium-pilocarpine model of epilepsy with chronic seizuresDongshuang Lu, Yang Ji, Padmavathi Sundaram, et al.
Chemical & Pharmaceutical Bulletin|September 6, 2005
Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenationAnna Miyazaki, Yutaka Fujisawa, Kimitaka Shiotani, et al.
Journal of Medicinal Chemistry|January 22, 2005
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2Tingyou Li, Yoshio Fujita, Yuko Tsuda, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platformKimitaka Shiotani, Tingyou Li, Anna Miyazaki, et al.
Bioorganic & Medicinal Chemistry|April 3, 2003
Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bondYoshio Okada, Yoshio Fujita, Takashi Motoyama, et al.
European Journal of Pharmacology|February 17, 2005
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouseYunden Jinsmaa, Yoshio Fujita, Kimitaka Shiotani, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationshipsKimitaka Shiotani, Anna Miyazaki, Tingyou Li, et al.
Journal of Medicinal Chemistry|May 15, 2007
Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligandsTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Brain Stimulation|November 14, 2013
Targeting of white matter tracts with transcranial magnetic stimulationAapo Nummenmaa, Jennifer A McNab, Peter Savadjiev, et al.
Journal of Medicinal Chemistry|July 11, 2003
Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesiaYoshio Okada, Yuko Tsuda, Yoshio Fujita, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Brain Research|February 8, 2021
Alkaline brain pH shift in rodent lithium-pilocarpine model of epilepsy with chronic seizuresDongshuang Lu, Yang Ji, Padmavathi Sundaram, et al.
Chemical & Pharmaceutical Bulletin|September 6, 2005
Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenationAnna Miyazaki, Yutaka Fujisawa, Kimitaka Shiotani, et al.
Journal of Medicinal Chemistry|January 22, 2005
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2Tingyou Li, Yoshio Fujita, Yuko Tsuda, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platformKimitaka Shiotani, Tingyou Li, Anna Miyazaki, et al.
Bioorganic & Medicinal Chemistry|April 3, 2003
Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bondYoshio Okada, Yoshio Fujita, Takashi Motoyama, et al.
European Journal of Pharmacology|February 17, 2005
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouseYunden Jinsmaa, Yoshio Fujita, Kimitaka Shiotani, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationshipsKimitaka Shiotani, Anna Miyazaki, Tingyou Li, et al.
Journal of Medicinal Chemistry|May 15, 2007
Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligandsTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Brain Stimulation|November 14, 2013
Targeting of white matter tracts with transcranial magnetic stimulationAapo Nummenmaa, Jennifer A McNab, Peter Savadjiev, et al.
Journal of Medicinal Chemistry|July 11, 2003
Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesiaYoshio Okada, Yuko Tsuda, Yoshio Fujita, et al.
Pageof 11